A/Prof Justin Chu and team (IMAGE)
Caption
NUS Medicine team of researchers who identified GW406108X as the new host-directed antiviral strategy. From left: Assoc Prof Justin Chu Jang Hann (NUS Medicine Principal Investigator), Dr Deborah Fong (NUS Medicine Post-graduate) and Dr Thinesshwary Yogarajah (NUS Medicine Senior Research Fellow).
Credit
NUS Medicine
Usage Restrictions
None
License
Original content